Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.
Press releases published on August 5, 2025
Avenio.ai Appoints Dr. Megha Vasavada as VP of Product Management to Accelerate GenAI in Clinical Trials & Operations
EIN Presswire
·
August 5, 2025
Dr. Megha Vasavada brings deep clinical research expertise to lead Avenio’s product strategy, advancing AI-driven efficiency across trial design and execution SAN FRANCISCO, CA, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Avenio.ai, the AI- …
Global tech leaders publish milestone review on tensor networks in quantum computing
EIN Presswire
·
August 5, 2025
Collaboration includes JPMorganChase, NVIDIA, Terra Quantum, Google, NASA, Quantinuum, and top academic institutions MUNICH, BAVARIA, GERMANY, August 5, 2025 /EINPresswire.com/ -- Over 30 researchers from JPMorganChase, NVIDIA, Terra Quantum, Google, …
Bath Products Bottle from Yuan Awarded Recycled Content Certification via SGS Green Marks Program
EIN Presswire
·
August 5, 2025
GENEVA, SWITZERLAND, August 5, 2025 /EINPresswire.com/ -- SGS, the world’s leading testing, inspection and certification company, has awarded SGS green marks certification to Taiwan-based personal care brand Yuan, verifying the recycled content of its …
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
August 5, 2025
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Three active immunotherapies for precision prevention of neurodegeneration progressing through Phase 2 clinical development ACI-7104.056 anti-alpha-synuclein active …
MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
August 5, 2025
Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the United States in mid-2026 Other clinical trials of …